Displaying drugs 1476 - 1500 of 1605 in total
Clebopride
Experimental
Clocortolone acetate
Experimental
D-leucyl-N-(3-chlorobenzyl)-L-prolinamide
Experimental
Eribaxaban
Experimental
GW-813893
Experimental
DA-6886
DA-6886 has been used in trials studying the treatment of Irritable Bowel Syndrome.
Investigational
HKI-357
Hki 357 is under investigation in clinical trial NCT00550381 (Study Evaluating the Safety, Tolerability, and Pharmacokinetics (PK) of HKI-357 Administered Orally to Healthy Subjects).
Investigational
Nizofenone
Experimental
Clometocillin
Experimental
Pyrotinib
Pyrotinib is under investigation in clinical trial NCT03756064 (Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer).
Investigational
Renzapride
Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). It has been suggested that renzapride is effective in the treatment of irritable bowel syndrome with alternating stool pattern. It is being developed by Alizyme of the UK.
Investigational
PRX-08066
Investigational
Meclinertant
Investigational
Fluralaner
Experimental
Vet approved
Displaying drugs 1476 - 1500 of 1605 in total